Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026)
Steris (STE) posted quarterly Non-Current Deferred Tax Liability of $390.7 million for Q1 2026, down 3.22% year-over-year from $403.7 million in Q1 2025, and down 5.74% quarter-over-quarter from $414.5 million in Q4 2025.
Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Steris' Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $390.7 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 3.22% year-over-year to $390.7 million; the TTM figure through Mar 2026 stood at $390.7 million (down 3.22% YoY), while the FY2026 annual figure was $390.7 million, down 3.22% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $390.7 million, down from $414.5 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $790.8 million in Q2 2022, with the low at $390.7 million in Q1 2026.
- The 5-year median for Non-Current Deferred Tax Liability is $479.7 million (2024), against an average of $550.6 million.
- The sharpest annual moves came in 2022 and 2024: Non-Current Deferred Tax Liability surged 229.57% in 2022, then declined 27.04% in 2024.
- Steris' Non-Current Deferred Tax Liability stood at $724.6 million in 2022, then slipped by 14.29% to $621.1 million in 2023, then slipped by 27.04% to $453.1 million in 2024, then fell by 8.52% to $414.5 million in 2025, then slipped by 5.74% to $390.7 million in 2026.
- Business Quant data shows STE's Non-Current Deferred Tax Liability at $390.7 million in Q1 2026, $414.5 million in Q4 2025, and $412.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 390.80 Mn |
| Jun 30, 2026 | 390.80 Mn |
| Mar 31, 2026 | 390.70 Mn |
| Mar 31, 2026 | 390.70 Mn |
| Dec 31, 2025 | 414.50 Mn |
| Dec 31, 2025 | 414.50 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Jun 30, 2025 | 411.40 Mn |
| Jun 30, 2025 | 411.40 Mn |
| Mar 31, 2025 | 403.70 Mn |
| Mar 31, 2025 | 403.70 Mn |
| Dec 31, 2024 | 453.13 Mn |
| Dec 31, 2024 | 453.13 Mn |
| Sep 30, 2024 | 462.74 Mn |
| Sep 30, 2024 | 462.74 Mn |
| Jun 30, 2024 | 456.47 Mn |
| Jun 30, 2024 | 456.47 Mn |
| Mar 31, 2024 | 479.69 Mn |
| Mar 31, 2024 | 479.69 Mn |